More Stories

Cardiology Testing March 5, 2026

What NT-proBNP Can Tell Us About TEER Outcomes March 5, 2026

New research presented at THT 2026 suggests that the NT-proBNP biomarker could give us a glimpse into which patients with severe tricuspid regurgitation (TR) will benefit the […]

Cardiology Testing March 2, 2026

Two Cardiac Troponins Don’t Tell the Same Story March 2, 2026

There might be a bigger difference between the types of cardiac troponin assays, after a recent JACC analysis found that the type of troponin could help us […]

Cardiovascular Disease February 26, 2026

Women’s CVD Will Keep Rising by 2050 February 26, 2026

Imagine an America where two out of three women suffer from cardiovascular disease. What would it look like for your mother, sister, or daughter? The American Heart […]

Surgeries & Interventions February 23, 2026

Market Competition Drives TAVR Overutilization February 23, 2026

Whether or not a patient receives TAVR over SAVR might be more influenced by market forces than clinical evidence, after a recent study found that the more […]

Surgeries & Interventions February 19, 2026

Evolut Low Risk, A Tale of Two Outcomes February 19, 2026

We might need to reconsider the concept of a TAVR-first strategy for low-risk aortic stenosis patients, after extended results from the Evolut Low Risk trial showed that […]

Heart Failure February 19, 2026

Rethinking Hyperkalemia Care in Patients With Heart Failure February 19, 2026

By Ravi Dhingra, MD, MPH, FACC, FAHASponsored By AstraZeneca Renin-angiotensin-aldosterone system inhibitor (RAASi) therapy is a cornerstone of heart failure (HF) management, yet concerns about hyperkalemia (HK) […]

Get twice-weekly insights on the biggest stories shaping cardiology.